* Omnicell Inc OMCL.OQ OMCL.O is expected to show a fall
in
quarterly revenue when it reports results on February 13
(estimated).
* The Santa Clara California-based company is expected to
report
a 7.8% decrease in revenue to $287.435 million from $311.72
million a year ago, according to the mean estimate from 9
analysts, based on Refinitiv data. The company's guidance on
November 2 2022, for the period ended December 31, was for
revenue between $285.00 million and $295.00 million.
* Refinitiv's mean analyst estimate for Omnicell Inc is for
earnings of 10 cents per share. The company's EPS guidance on
November 2 2022, for the period ended December 31, was between
$0.05 and $0.15
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Omnicell
Inc is
$66, above its last closing price of $54.22.
The company's guidance on November 2 2022 for the period ended
December 31 was for Earnings before Interest, Taxes,
Depreciation and Amortization of between USD285 million and
USD16 million.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 0.95 0.95 1.00 Beat 4.8
Jun. 30 2022 0.85 0.85 0.84 Missed -1.2
Mar. 31 2022 0.68 0.69 0.83 Beat 21.2
Dec. 31 2021 0.92 0.92 0.92 Met -0.3
Sep. 0.91 0.91 1.08 Beat 18.4
30 2021
Jun. 30 2021 0.83 0.83 0.97 Beat 17.3
Mar. 31 2021 0.66 0.66 0.83 Beat 25.8
Dec. 31 2020 0.81 0.80 0.91 Beat 13.3
This summary was machine generated February 10 at 11:49 GMT.
All figures in US dollars unless otherwise stated